Listar por autor "Maggioni, Aldo P."
Mostrando ítems 21-32 de 32
-
Ischemic cardiomyopathy versus non-ischemic dilated cardiomyopathy in patients with reduced ejection fraction-clinical characteristics and prognosis depending on heart failure etiology (data from European Society of Cardiology heart failure registries)
Tyminska, Agata; Ozieranski, Krzysztof; Balsam, Pawel; Maciejewski, Cezary; Wancerz, Anna; Brociek, Emil; Marchel, Michal; Crespo-Leiro, María Generosa; Maggioni, Aldo P.; Drozdz, Jaroslaw; Opolski, Grzegorz; Grabowski, Marcin; Kapłon-Cieslicka, Agnieszka (MDPI, 2022-02-21)[Abstract] Personalized management involving heart failure (HF) etiology is crucial for better prognoses for HF patients. This study aimed to compare patients with ischemic cardiomyopathy (ICM) and patients with non-ischemic ... -
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure
Savarese, Gianluigi; Gatti, Paolo; Benson, Lina; Adamo, Marianna; Chioncel, Ovidiu; Crespo-Leiro, María Generosa; Anker, Stefan D.; Coats, Andrew J.S.; Filippatos, Gerasimos; Lainscak, Mitja; Mcdonagh, Theresa; Mebazaa, Alexandre; Metra, Marco; Piepoli, Massimo; Rosano, Giuseppe M.; Ruschitzka, Frank; Seferovic, Petar; Volterrani, Maurizio; Maggioni, Aldo P.; Lund, Lars H. (Elsevier, 2023-11-15)[Abstract] Aims: Aims were to evaluate (1) reclassification of patients from heart failure with mildly reduced (HFmrEF) to reduced (HFrEF) ejection fraction when an EF = 40% was considered as HFrEF, (2) role of EF digit ... -
Long term safety of inotropes and/or vasopressors in acute heart failure: results from ESC-HF-LT registry
Mebazaa, Alexandre; Motiejunaite, Justina; Gayat, Etienne; Akiyama, Eiichi; Crespo-Leiro, María Generosa; Lund, Lars H.; Maggioni, Aldo P.; Chioncel, Ovidiu; Ruschitzka, Frank; Filippatos, Gerasimos (Wiley, 2017) -
Long‐term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long‐Term Registry
Mebazaa, Alexandre; Motiejunaite, Justina; Gayat, Etienne; Crespo-Leiro, María Generosa; Lund, Lars H.; Maggioni, Aldo P.; Chioncel, Ovidiu; Akiyama, Eiichi; Harjola, Veli-Pekka; Seferovic, Petar M.; Laroche, Cécile; Sanz Julve, Marisa; Roig, Eulàlia; Ruschitzka, Frank; Filippatos, Gerasimos (Wiley, 2017-10-08)[Abstract] Aims. The aim of this study was to assess long‐term safety of intravenous cardiovascular agents—vasodilators, inotropes and/or vasopressors—in acute heart failure (AHF). Methods and results. The European Society ... -
One-year outcome in patients with heart failure with mid-range ejection fraction hospitalized due to worsening heart failure
Marchel, Michal; Tyminska, Agata; Kaplon-Cieslicka, Agnieszka; Ozieranski, Krzysztof; Peller, Michal; Balsam, Pawel; Crespo-Leiro, María Generosa; Maggioni, Aldo P.; Drozdz, Jaroslaw; Filipiak, Krzysztof J.; Opolski, Grzegorz (2017) -
Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry
Kapelios, Chris J.; Benson, Lina; Crespo-Leiro, María Generosa; Anker, Stefan; Coats, Andrew J.S.; Chioncel, Ovidiu; Filippatos, Gerasimos; Lainscak, Mitja; McDonagh, Theresa; Mebazaa, Alexandre; Metra, Marco; Piepoli, Massimo F.; Rosano, Giuseppe M.C.; Ruschitzka, Frank; Savarese, Gianluigi; Seferovic, Petar M.; Volterrani, Maurizio; Maggioni, Aldo P.; Lund, Lars H. (2023-03-04) -
Prognostic implications of atrial fibrillation in heart failure with reduced, mid-range, and preserved ejection fraction: a report from 14 964 patients in the European Society of Cardiology Heart Failure Long-Term Registry
Zafrir, Barak; Lund, Lars H.; Laroche, Cecile; Ruschitzka, Frank; Crespo-Leiro, María Generosa; Coats, Andrew J.S.; Anker, Stefan; Filippatos, Gerasimos; Seferovic, Petar M.; Maggioni, Aldo P.; Mora Martín, Manuel De; Polonski, Lech; Silva-Cardoso, José; Amir, Offer (Oxford, 2018-10-15)[Abstract] Aim. To investigate the characteristics long-term prognostic implications (up to ∼2.2 years) of atrial fibrillation (AF) compared to sinus rhythm (SR), between acute and chronic heart failure (HF) with reduced ... -
Rationale and design of the ESC Heart Failure III Registry – Implementation and discovery
Lund, Lars H.; Crespo-Leiro, María Generosa; Laroche, Cecile; García-Pinilla, José M.; Bennis, Ahmed; Vataman, Eleonora B.; Polovina, Marija; Radovanovic, Slavica; Apostolovic, Svetlana R.; Asanin, Milika; Gackowski, Andrzej; Kaplon-Cieslicka, Agnieszka; Cabac-Pogorevici, Irina; Anker, Stefan D.; Chioncel, Ovidiu; Coats, Andrew J.S.; Filippatos, Gerasimos; Lainscak, Mitja; Mcdonagh, Theresa; Mebazaa, Alexandre; Metra, Marco; Piepoli, Massimo; Rosano, Giuseppe M.; Ruschitzka, Frank; Savarese, Gianluigi; Seferovic, Petar; Lung, Bernard; Popescu, Bogdan A.; Maggioni, Aldo P. (John Wiley & Sons, 2023-11-21)[Abstract] Aims: Heart failure outcomes remain poor despite advances in therapy. The European Society of Cardiology Heart Failure III Registry (ESC HF III Registry) aims to characterize HF clinical features and outcomes ... -
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
Kapelios, Chris J.; Lainscak, Mitja; Savarese, Gianluigi; Laroche, Cécile; Seferovic, Petar; Ruschitzka, Frank; Coats, Andrew; Anker, Stefan; Crespo-Leiro, María Generosa; Filippatos, Gerasimos; Piepoli, Massimo; Rosano, Giuseppe; Zanolla, Luisa; Aguiar, Carlos; Murin, Jan; Leszek, Przemyslaw; McDonagh, Theresa; Maggioni, Aldo P.; Lund, Lars H. (Wiley, 2019-05-27)[Abstract] Aims: To assess the proportion of patients with heart failure and reduced ejection fraction (HFrEF) who are eligible for sacubitril/valsartan (LCZ696) based on the European Medicines Agency/Food and Drug ... -
Sex‐ and Age‐Related Differences in the Management and Outcomes of Chronic Heart Failure: an Analysis of Patients from the ESC HFA EORP Heart Failure Long‐Term Registry
Lainscak, Mitja; Milinković, Ivan; Polovina, Marija; Crespo-Leiro, María Generosa; Lund, Lars H.; Anker, Stefan; Laroche, Cécile; Ferrari, Roberto; Coats, Andrew J.S.; McDonagh, Theresa A.; Filippatos, Gerasimos; Maggioni, Aldo P.; Piepoli, Massimo Francesco; Rosano, Giuseppe; Ruschitzka, Frank; Simić, Dragan; Ašanin, Milika; Eicher, Jean‐Christophe; Yilmaz, Mehmet Birhan; Seferovic, Petar M. (Willey, 2019-12-20)[Abstract] Aims. This study aimed to assess age‐ and sex‐related differences in management and 1‐year risk for all‐cause mortality and hospitalization in chronic heart failure (HF) patients. Methods and results. Of ... -
The prevalence and association of major ECG abnormalities with clinical characteristics and the outcomes of real-life heart failure patients - Heart Failure Registries of the European Society of Cardiology
Tyminska, Agata; Ozieranski, Krzysztof; Balsam, Pawel; Kaplon-Cieslicka, Agnieszka; Maciejewski, Cezary; Marchel, Michal; Crespo-Leiro, María Generosa; Maggioni, Aldo P.; Drozdz, Jaroslaw; Filipiak, Krzysztof J.; Opolski, Grzegorz; Grabowski, Marcin (Via Medica, 2021-06-02)[Abstract] Background: Electrocardiogram (ECG) abnormalities increase the likelihood of heart failure (HF) but have low specificity and their occurrence is multifactorial. Aim: This study aimed to investigate the prevalence ... -
Unravelling the Interplay Between Hyperkalaemia, Renin–Angiotensin–Aldosterone Inhibitor Use and Clinical Outcomes. Data From 9222 Chronic Heart Failure Patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry
Rossignol, Patrick; Lainscak, Mitja; Crespo-Leiro, María Generosa; Laroche, Cécile; Piepoli, Massimo Francesco; Filippatos, Gerasimos; Rosano, Giuseppe; Savarese, Gianluigi; Anker, Stefan; Seferovic, Petar M.; Ruschitzka, Frank; Coats, Andrew J.S.; Mebazaa, Alexandre; McDonagh, Theresa; Sahuquillo-Martínez, Ana; Penco, María; Maggioni, Aldo P.; Lund, Lars H. (Willey Online Library, 2020-04-03)[Abstract] Aims. We assessed the interplay between hyperkalaemia (HK) and renin–angiotensin–aldosterone system inhibitor (RAASi) use, dose and discontinuation, and their association with all‐cause or cardiovascular death ...